Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Random SARS-CoV-2 antibody screening in Egypt during the COVID-19 third wave

Type de record:

paper
Créateur:
MahMarHebHen
Éditeur:
Egy
Hôte:

Visit

doi.org

Similaires

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in KenyaTemporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in KenyaReplication Data for: Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in KenyaSARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The GambiaSARS-CoV-2 and neutralizing antibody dynamics at a remote village in Kenya before widespread COVID-19 vaccine rolloutRestoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2 pandemic

Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya

Abstract Observed SARS-CoV-2 infections and deaths are low in tropical Africa ra

Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya

Abstract Observed SARS-CoV-2 infections and deaths are low in tropical Africa rais

Replication Data for: Temporal trends of SARS-CoV-2 seroprevalence in transfusion blood donors during the first wave of the COVID-19 epidemic in Kenya

This is a replication dataset for the manuscriot titled: "Temporal trends

SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia

Abstract Objectives SARS-CoV-2 transmissio

SARS-CoV-2 and neutralizing antibody dynamics at a remote village in Kenya before widespread COVID-19 vaccine rollout

Given limited data on SARS‑CoV‑2 transmission and immunity in rural, low‑vaccine‑coverage settings,

Restoring non-COVID-19 clinical research and surveillance in Oyo state, Nigeria during the SARS-CoV-2 pandemic

Background: Many sub-Saharan African patients receive clinical care from extramurally-supported rese